National Institute on Drug Abuse; Notice of Closed Meeting, 13397 [2021-04694]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 43 / Monday, March 8, 2021 / Notices
Estimated Total Annual Burden
Hours: 3,440.
Authority: The Family Violence Prevention
and Services Act, 42 U.S.C. 10401.
Dated: March 2, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–04695 Filed 3–5–21; 8:45 am]
Mary B. Jones,
Bureau of Land Management
[21X.LLAZ921000.L14400000.
BJ0000.LXSSA2250000.241A]
Notice of Filing of Plats of Survey;
Arizona
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2021–04776 Filed 3–5–21; 8:45 am]
BILLING CODE 4184–32–P
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute on Drug Abuse;
Notice of Closed Meeting
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
jbell on DSKJLSW7X2PROD with NOTICES
DEPARTMENT OF THE INTERIOR
BILLING CODE 4140–01–P
ACF/OPRE Certifying Officer.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel; Career Development
(Ks) and Conference support (R13) Review.
Date: March 18, 2021.
Time: 9:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Democracy II, 6707 Democracy Blvd.,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: John P. Holden, Ph.D.,
Scientific Review Officer, National Institute
of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707
Democracy Blvd., Suite 920, Bethesda, MD
20892, (301) 496–8775, john.holden@
mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the urgent
need to meet timing limitations imposed by
the review and funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, National Institute of
Biomedical Imaging and Bioengineering,
National Institutes of Health, HHS)
VerDate Sep<11>2014
13397
19:05 Mar 05, 2021
Jkt 253001
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Elucidation of mechanisms underlying
complex morbidities of SUD and other
mental Illnesses in people living with HIV/
AIDS (R01 Clinical Trial Optional).
Date: April 7, 2021.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Drug Abuse, 301 North
Stonestreet Avenue, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Soyoun Cho, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research,
National Institute on Drug Abuse, NIH, 301
North Stonestreet Avenue, MSC 6021,
Bethesda, MD 20892, (301) 594–9460,
Soyoun.cho@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.277, Drug Abuse Scientist
Development Award for Clinicians, Scientist
Development Awards, and Research Scientist
Awards; 93.278, Drug Abuse National
Research Service Awards for Research
Training; 93.279, Drug Abuse and Addiction
Research Programs, National Institutes of
Health, HHS)
Dated: March 2, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–04694 Filed 3–5–21; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00119
Fmt 4703
Sfmt 4703
Bureau of Land Management,
Interior.
ACTION: Notice of official filing.
AGENCY:
The plats of survey of the
following described lands are scheduled
to be officially filed 30 days after the
date of this publication in the Bureau of
Land Management (BLM), Arizona State
Office, Phoenix, Arizona. The surveys
announced in this notice are necessary
for the management of lands
administered by the agency indicated.
ADDRESSES: These plats will be available
for inspection in the Arizona State
Office, Bureau of Land Management,
One North Central Avenue, Suite 800,
Phoenix, Arizona 85004–4427. Protests
of any of these surveys should be sent
to the Arizona State Director at the
above address.
FOR FURTHER INFORMATION CONTACT:
Mark Morberg, Chief Cadastral Surveyor
of Arizona; (602) 417–9558; mmorberg@
blm.gov. Persons who use a
telecommunications device for the deaf
(TDD) may call the Federal Relay
Service (FRS) at 1–800–877–8339 to
contact the above individual during
normal business hours. The FRS is
available 24 hours a day, 7 days a week,
to leave a message or question with the
above individual. You will receive a
reply during normal business hours.
SUPPLEMENTARY INFORMATION:
SUMMARY:
The Gila and Salt River Meridian,
Arizona
The plat, in four sheets, representing
the dependent resurvey of a portion of
the Gila and Salt River Meridian (east
boundary), portions of the west and
north boundaries and a portion of the
subdivisional lines, the subdivision of
certain sections, and a metes-andbounds survey of a portion of the Luke
Air Force Base boundary, Township 2
North, Range 1 West, accepted January
13, 2021, for Group 1194, Arizona.
This plat was prepared at the request
of the United States Air Force.
The plat, in one sheet, representing
the dependent resurvey of a portion of
the subdivisional lines, the subdivision
of sections 32 and 33, and a metes-andbounds survey of a portion of the Luke
Air Force Base boundary, Township 3
North, Range 1 West, accepted January
13, 2021, for Group 1194, Arizona.
E:\FR\FM\08MRN1.SGM
08MRN1
]]>Agencies
[Federal Register Volume 86, Number 43 (Monday, March 8, 2021)]
[Notices]
[Page 13397]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-04694]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Elucidation of mechanisms underlying complex
morbidities of SUD and other mental Illnesses in people living with
HIV/AIDS (R01 Clinical Trial Optional).
Date: April 7, 2021.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Institute on Drug
Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Soyoun Cho, Ph.D., Scientific Review Officer,
Scientific Review Branch, Division of Extramural Research, National
Institute on Drug Abuse, NIH, 301 North Stonestreet Avenue, MSC
6021, Bethesda, MD 20892, (301) 594-9460, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug
Abuse Scientist Development Award for Clinicians, Scientist
Development Awards, and Research Scientist Awards; 93.278, Drug
Abuse National Research Service Awards for Research Training;
93.279, Drug Abuse and Addiction Research Programs, National
Institutes of Health, HHS)
Dated: March 2, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-04694 Filed 3-5-21; 8:45 am]
BILLING CODE 4140-01-P
